NIH × Amplified Fragment Length Polymorphism Analysis × Genitourinary × Clear all Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
Phase 2 Completed
73 enrolled 16 charts
Study of a Polymorphism in Patients With Prostate Cancer
Completed
750 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Phase NA Unknown
2,200 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
2,000 enrolled
DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE
Completed